BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 9841920)

  • 1. Stat5b is essential for natural killer cell-mediated proliferation and cytolytic activity.
    Imada K; Bloom ET; Nakajima H; Horvath-Arcidiacono JA; Udy GB; Davey HW; Leonard WJ
    J Exp Med; 1998 Dec; 188(11):2067-74. PubMed ID: 9841920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both stat5a and stat5b are required for antigen-induced eosinophil and T-cell recruitment into the tissue.
    Kagami Si; Nakajima H; Kumano K; Suzuki K; Suto A; Imada K; Davey HW; Saito Y; Takatsu K; Leonard WJ; Iwamoto I
    Blood; 2000 Feb; 95(4):1370-7. PubMed ID: 10666213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of cytokine differential induction of STAT complexes in primary human T and NK cells.
    Yu CR; Young HA; Ortaldo JR
    J Leukoc Biol; 1998 Aug; 64(2):245-58. PubMed ID: 9715265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferation and differentiation of CD8+ T cells in the absence of IL-2/15 receptor beta-chain expression or STAT5 activation.
    Teague RM; Tempero RM; Thomas S; Murali-Krishna K; Nelson BH
    J Immunol; 2004 Sep; 173(5):3131-9. PubMed ID: 15322173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor alpha chain induction.
    Nakajima H; Liu XW; Wynshaw-Boris A; Rosenthal LA; Imada K; Finbloom DS; Hennighausen L; Leonard WJ
    Immunity; 1997 Nov; 7(5):691-701. PubMed ID: 9390692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of Stat5a and Stat5b in signaling by IL-2 family cytokines.
    Lin JX; Leonard WJ
    Oncogene; 2000 May; 19(21):2566-76. PubMed ID: 10851055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid binding activity of Stat5A and Stat5B.
    Smit LS; Vanderkuur JA; Stimage A; Han Y; Luo G; Yu-Lee LY; Schwartz J; Carter-Su C
    Endocrinology; 1997 Aug; 138(8):3426-34. PubMed ID: 9231797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Culturing the Human Natural Killer Cell Line NK-92 in Interleukin-2 and Interleukin-15 - Implications for Clinical Trials.
    Törnroos H; Hägerstrand H; Lindqvist C
    Anticancer Res; 2019 Jan; 39(1):107-112. PubMed ID: 30591446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin 2 and interleukin 15 differentially predispose natural killer cells to apoptosis mediated by endothelial and tumour cells.
    Rodella L; Zamai L; Rezzani R; Artico M; Peri G; Falconi M; Facchini A; Pelusi G; Vitale M
    Br J Haematol; 2001 Nov; 115(2):442-50. PubMed ID: 11703348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A programmed switch from IL-15- to IL-2-dependent activation in human NK cells.
    Pillet AH; Bugault F; Thèze J; Chakrabarti LA; Rose T
    J Immunol; 2009 May; 182(10):6267-77. PubMed ID: 19414780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental regulation of STAT gene expression reveals an involvement of STAT5 in interleukin-4-driven cell proliferation.
    Friedrich K; Wietek S
    Biol Chem; 2001 Feb; 382(2):343-51. PubMed ID: 11308032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human signal transducer and activator of transcription 5b (STAT5b) mutation causes dysregulated human natural killer cell maturation and impaired lytic function.
    Vargas-Hernández A; Witalisz-Siepracka A; Prchal-Murphy M; Klein K; Mahapatra S; Al-Herz W; Mace EM; Carisey AF; Orange JS; Sexl V; Forbes LR
    J Allergy Clin Immunol; 2020 Jan; 145(1):345-357.e9. PubMed ID: 31600547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A point mutation in the linker domain of mouse STAT5A is associated with impaired NK-cell regulation.
    Chehboun S; Leiva-Torres GA; Charbonneau B; Eveleigh R; Bourque G; Vidal SM
    Genes Immun; 2020 Feb; 21(2):136-141. PubMed ID: 31591503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling through JAK2-STAT5 pathway is essential for IL-3-induced activation of microglia.
    Natarajan C; Sriram S; Muthian G; Bright JJ
    Glia; 2004 Jan; 45(2):188-96. PubMed ID: 14730712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin (IL)-2 and IL-15 have different effects on human natural killer lymphocytes.
    Pillet AH; Thèze J; Rose T
    Hum Immunol; 2011 Nov; 72(11):1013-7. PubMed ID: 21925225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal transducer and activator of transcription 5 activation is sufficient to drive transcriptional induction of cyclin D2 gene and proliferation of rat pancreatic beta-cells.
    Friedrichsen BN; Richter HE; Hansen JA; Rhodes CJ; Nielsen JH; Billestrup N; Møldrup A
    Mol Endocrinol; 2003 May; 17(5):945-58. PubMed ID: 12586844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 2-induced proliferation of murine natural killer cells in vivo.
    Biron CA; Young HA; Kasaian MT
    J Exp Med; 1990 Jan; 171(1):173-88. PubMed ID: 1688606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-2 (IL-2) receptor-betagamma signalling is activated by c-Kit in the absence of IL-2, or by exogenous IL-2 via JAK3/STAT5 in human papillomavirus-associated cervical cancer.
    Rocha-Zavaleta L; Huitron C; Cacéres-Cortés JR; Alvarado-Moreno JA; Valle-Mendiola A; Soto-Cruz I; Weiss-Steider B; Rangel-Corona R
    Cell Signal; 2004 Nov; 16(11):1239-47. PubMed ID: 15337523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective interleukin (IL)-18-mediated natural killer and T helper cell type 1 responses in IL-1 receptor-associated kinase (IRAK)-deficient mice.
    Kanakaraj P; Ngo K; Wu Y; Angulo A; Ghazal P; Harris CA; Siekierka JJ; Peterson PA; Fung-Leung WP
    J Exp Med; 1999 Apr; 189(7):1129-38. PubMed ID: 10190904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.